Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace

What makes the dollar strong?

Aug 23, 2019

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
This Is Uncomfortable
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy

Cancer death rates have fallen 27 percent

by Andy Uhler Jan 9, 2019
Oncology experts say advances in cancer drugs have played a major role.
Cathy Bradley says many cancer patients stay at work because they need the health insurance their employer provides.
Justin Sullivan/Getty Images

Deals aimed at reining in costs of cancer drugs show promise

by Dan Gorenstein Jun 6, 2016
Some manufacturers are willing to tie drug price to performance.
Dr. Julie Brahmer (R) and Katie Thornton review PET (Positron Emission Tomography) scans of a patient being treated at the Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Maryland. 
Win McNamee/Getty Images

Cigna deal calls for rebates if drugs don't perform

by Dan Gorenstein May 11, 2016
It's the seventh such deal for the insurance giant, which is putting pressure on drug makers in an effort to keep costs down.
Rosemary Petty, a Publix Supermarket pharmacy technician, counts out a prescription August 7, 2007 in Miami, Florida. 
Joe Raedle/Getty Images

FTC fights against new strategy for delaying generics

by Dan Gorenstein Apr 1, 2016
FTC files case against drug maker for deals cut with two generic firms that extend its monopoly
John Moore/Getty Images

Why rare-disease treatments can be big business

by Annie Baxter Jan 11, 2016
Combined, Shire and Baxalta expect 65 percent of total revenue to come from rare disease treatments.

Police turn to pricey rehab drug for offenders

by Miles Bryan Nov 4, 2015
The drug, administered once a month, helps ensure patient compliance.

Valeant: how aggressively can a drug company sell

by Mitchell Hartman Oct 30, 2015
Valeant is under scrutiny for its business practices.

Invest in Marketplace today

Ask not what Marketplace can do for you, but what you can do for Marketplace.

Drug company's subsidies to patients under review

by Annie Baxter Oct 15, 2015
Assistance programs are also marketing tools that can raise overall costs.